The role of galanin in feeding behavior

Neuropeptides

Volumn 33, Issue 5, 1999, Pages 369-375

  Crawley, J N ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING AGENT; GALANIN; GALANIN RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; APPETITE DISORDER; BODY WEIGHT; FEEDING BEHAVIOR; FOOD INTAKE; INGESTION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SATIETY;

ANIMALIA;

EID: 0032705681     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.1999.0049     Document Type: Article

References (69)

1. Tatemoto K., Rökaeus Å., Jörnvall H., McDonald T., Mutt V. Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett. 164:1983;124-128.
2. Hökfelt, T.Bartfai, T.Crawley, J. N. Galanin: Basic Research and Therapeutic Indications, Ann N Y Acad Sci, 1998.
3. Crawley J. N. Biological actions of galanin. Regulatory Peptides. 59:1995;1-16.
4. Bartfai T., Fisone G., Langel Ü. Galanin and galanin antagonists: molecular and biochemical properties. Trends Pharmacol Sci. 13:1992;312-317.
5. Hökfelt T., Millhorn D., Seroogy K., Tsuruo Y., Cecatelli S., Lindh B., Meister B., Melander T., Schalling M., Bartfai T., Terenius T. Coexistence of peptides with classical transmitters. Experientia. 43:1987;768-780.
6. Smith K. E., Walker M. W., Artymyshyn R., Bard J., Borowsky B., Tamm J. A., Yao W. J., Vaysse P. J. J., Branchek T. A., Gerald C., Jones K. A. Cloned human and rat galanin GALR3 receptors. J Biol Chem. 1998;23,321-23,326.
7. Merchenthaler I., Lopez F. J., Negro-Vilar A. Anatomy and physiology of central galanin-containing pathways. Prog Neurobiol. 1993;711-769.
8. Kyrkouli S. E., Stanley B. G., Leibowitz S. F. Galanin: Stimulation of feeding induced by medial hypothalamic injection of this novel peptide. Eur J Pharmacol. 122:1986;159-160.
9. Kyrkouli S. E., Stanley B. G., Seirafi R. D., Leibowitz S. F. Stimulation of feeding by galanin: Anatomical localization and behavioral specificity of this peptide's effects in the brain. Peptides. 11:1990;995-1001.
10. Barton C., Lin L., York D. A., Bray G. A. Differential effects of enterostatin, galanin and opioids on high-fat diet consumption. Brain Res. 702:1995;55-60.
11. Crawley J. N., Austin M. C., Fiske S. M., Martin B., Consolo S., Berthold M., Langel Ü., Fisone G., Bartfai T. Activity of centrally administered galanin fragments on stimulation of feeding behavior and on galanin receptor binding in the rat hypothalamus. J Neurosci. 10:1990;3695-3700.
12. Dube M. G., Horvath T. L., Leranth C., Kalra P. S., Kalra S. P. Naloxone reduces the feeding evoked by intracerebroventricular galanin injection. Physiol Behav. 56:1994;811-813.
13. Koegler F. H., Ritter S. Galanin injection into the nucleus of the solitary tract stimulates feeding in rats with lesions of the paraventricular nucleus of the hypothalamus. Physiol Behav. 63:1998;521-527.
14. Schick R. R., Samsami S., Zimmermann J. P., Eberl T., Endres C., Schusdziarra V., Classen M. Effect of galanin on food intake in rats: involvement of lateral and ventromedial hypothalamic sites. Am J Physiol. 264:1993;R355-R361.
15. Hökfelt T., Bartfai T., Jacobowitz D., Ottoson D. Galanin: A New Multifunctional Peptide in the Neuro-endocrine System. 1991;MacMillan Press; London.
16. Campfield L. A., Smith F. J., Burn P. Strategies and potential molecular targets for obesity treatment. Science. 280:1998;1383-1387.
17. Rowland N. E., Kalra S. P. Potential role of neuropeptide ligands in the treatment of overeating. CNS Drugs. 7:1997;419-426.
18. Woods S. C., Seeley R. J., Porte D., Schwartz M. W. Signals that regulate food intake and energy homeostasis. Science. 280:1998;1378-1383.
19. Crawley J. N., Robinson J. K., Langel Ü., Bartfai T. Galanin receptor antagonists M40 and C7 block galanin-induced feeding. Brain Res. 600:1993;268-272.
20. Wang S., Ghibaudi L., Hashemi T., He C., Strader C., Bayne M., Davis H., Hwa J. J. The GalR2 galanin receptor mediates galanin-induced jejunal contraction, but not feeding behavior, in the rat: differentiation of central and peripheral effects of receptor subtype activation. FEBS Lett. 434:1998;277-282.
21. Lin L., York D. A., Bray G. A. Comparison of Osborne-Mendel and S5B/PL strains of rat: central effects of galanin, NPY, β-casomorphin and CRH on intake of high-fat and low-fat diets. Obesity Res. 4:1996;117-124.
22. Koegler F. H., Ritter S. Aqueduct occlusion does not impair feeding induced by either third or fourth ventricle galanin injection. Obesity Res. 5:1997;262-267.
23. 2-adrenergic receptors in goldfish. Regulatory Peptides. 57:1995;77-84.
24. Boswell T., Richardson R. D., Schwartz M. W., D'Alessio D. A., Woods S. C., Sipols A. J., Baskin D. G., Kenagy G. J. NPY and galanin in a hibernator: hypothalamic gene expression and effects on feeding. Brain Res Bull. 32:1993;379-384.
25. Tempel D. L., Leibowitz K. J., Leibowitz S. F. Effects of PVN galanin on macronutrient selection. Peptides. 9:1988;309-314.
26. Tempel D. L., Leibowitz S. F. Diurnal variations in the feeding responses to norepinephrine, neuropeptide Y and galanin in the PVN. Brain Res Bull. 25:1990;821-825.
27. Kyrkouli S. E., Stanley B. G., Hutchinson R., Seirafi R. D., Leibowitz S. F. Peptide-amine interactions in the hypothalamic paraventricular nucleus: analysis of galanin and neuropeptide Y in relation to feeding. Brain Res. 521:1990;185-191.
28. Bartfai T., Langel Ü., Bedecs K., Andell S., Land T., Gregersen S., Xu X., Wiesenfeld-Hallin Z., Hökfelt T. Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes. Proc Natl Acad Sci USA. 90:1993;11,287-11,291.
29. Corwin R. L., Robinson J. K., Crawley J. N. Galanin antagonists block galanin-induced feeding in the hypothalamus and amygdala of the rat. Eur J Neurosci. 5:1993;1528-1533.
30. Koegler F. H., Ritter S. Feeding induced by pharmacological blockade of fatty acid metabolism is selectively attenuated by hindbrain injections of the galanin receptor antagonist, M40. Obesity Res. 4:1996;329-336.
31. Crawley, J. N. Institute of Mental Health, Bethesda, MD, unpublished data, illustrated in Figure 1, bottom.
32. Kyrkouli S. E., Stanley B. G., Leibowitz S. F. Differential effects of galanin and neuropeptide Y on extracellular norepinephrine levels in the paraventricular hypothalamic nucleus of the rat: a microdialysis study. Life Sci. 51:1992;203-210.
33. Rada P., Mark G., Hoebel B. G. Galanin in the hypothalamus raises dopamine and lowers acetylcholine release in the nucleus accumbens: a possible mechanism for hypothalamic initiation of feeding behavior. Brain Res. 798:1998;1-6.
34. Halaas J. L., Gajiwala K. S., Maffel M., Cohen S. L., Chait B. T., Rabinowitz D., Lallone R. L., Burley S. K., Friedman J. M. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269:1995;546-549.
35. Schwartz M. W., Seeley R. J., Campfield L. A., Burn P., Baskin D. B. Identification of targets of leptin action in the rat hypothalamus. J Clin Invest. 98:1996;1101-1106.
36. Sahu A. Leptin decreases food intake induced by melanin-concentrating hormone (MCH), galanin (GAL) and neuropeptide Y (NPY) in the rat. Endocrinol. 129:1998;4739-4742.
37. Akabayashi A., Koenig J. I., Watanabe Y., Alexander J. T., Leibowitz S. F. Galanin-containing neurons in the paraventricular nucleus: a neurochemical marker for fat ingestion and body weight gain. Proc Natl Acad Sci USA. 91:1994;10,375-10,379.
38. Leibowitz S. F., Akabayashi A., Wang J. Obesity of a high-fat diet: role of hypothalamic galanin in neurons of the anterior paraventricular nucleus projecting to the median eminence. J Neurosci. 18:1998;2709-2719.
39. Mercer J. G., Lawrence C. B., Atkinson T. Regulation of galanin gene expression in the hypothalamic paraventricular nucleus of the obese Zucker rat by manipulation of dietary macronutrients. Mol Brain Res. 43:1996;202-208.
40. Pedrazzi P., Cattaneo L., Valeriani L., Boschi S., Cocchi D., Zoli M. Hypothalamic neuropeptide Y and galanin in overweight rats fed a cafeteria diet. Peptides. 19:1998;157-165.
41. Beck B., Burlet A., Nicolas J. P., Burlet C. Galanin in the hypothalamus of fed and fasted lean and obese Zucker rats. Brain Res. 623:1993;124-130.
42. Plagemann A., Harder T., Rake A., Melchior K., Rohde W., Dörner G. Increased number of galanin-neurons in the paraventricular hypothalamic nucleus of neonatally overfed weanling rats. Brain Res. 1999;160-163.
43. Brady L. S., Smith M. A., Gold P. W., Herkenham M. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinol. 52:1990;441-447.
44. Schwartz M. W., Sipols A. J., Grubin C. E., Baskin D. G. Differential effect of fasting on hypothalamic expression of genes encoding neuropeptide Y, galanin, and glutamic acid decarboxylase. Brain Res Bull. 31:1993;361-367.
45. Jhanwar-Uniyal M., Chua S. C. Critical effects of aging and nutritional state on hypothalamic neuropeptide Y and galanin gene expression in lean and genetically obese Zucker rats. Mol Brain Res. 19:1993;195-202.
46. McShane T. M., Wilson M. E., Wise P. M. Effects of lifelong moderate caloric restriction on levels of neuropeptide Y, proopiomelanocortin, and galanin mRNA. J Gerontol. 54A:1999;B14-B21.
47. Wang J., Leibowitz K. L. Central insulin inhibits hypothalamic galanin and neuropeptide Y gene expression and peptide release in intact rats. Brain Res. 777:1997;231-236.
48. Gorbatyuk O., Hökfelt T. Effect of inhibition of glucose and fat metabolism on galanin-R1 receptor mRNA levels in the rat hypothalamic paraventricular and supraoptic nuclei. Neuroreport. 9:1998;3565-3569.
49. Sahu A. Evidence suggesting that galanin (GAL), melanin-concentrating hormone (MCH), neurotensin (NT), proopiomelanocortin (POMC) and neuropeptide Y (NPY) are targets of leptin signaling in the hypothalamus. Endocrinol. 139:1998;795-798.
50. Leibowitz S. F., Akabayashi A., Wang J. Obesity on a high-fat diet: role of hypothalamic galanin in neurons of the anterior paraventricular nucleus projecting to the median eminence. J Neurosci. 1998;18; 2709-2719.
51. Smith B. K., Berthoud H. R., York D. A., Bray G. A. Differential effects of baseline macronutrient preferences on macronutrient selection after galanin, NPY, and an overnight fast. Peptides. 18:1997;207-211.
52. Smith B. K., York D. A., Bray G. A. Chronic cerebroventricular galanin does not induce sustained hyperphagia or obesity. Peptides. 7:1994;1267-1272.
53. Corwin R. L., Rowe P. M., Crawley J. N. Galanin and the galanin antagonist M40 do not change fat intake in a fat-chow choice paradigm in rats. Am J Physiol. 269:1995;R511-R518.
54. Crawley J. N., Robinson J. K., Langel Ü., Bartfai T. Galanin receptor antagonists M40 and C7 block galanin-induced feeding. Brain Res. 600:1993;268-272.
55. Leibowitz S. F., Kim T. Impact of a galanin antagonist on exogenous galanin and natural patterns of fat ingestion. Brain Res. 599:1992;148-152.
56. Wynick D., Small C. J., Bacon A., Holmes F. E., Norman M., Ormandy C. J., Kilic E., Kerr N. C. H., Ghatei M., Talamantes F., Bloom S. R., Pachnis V. Galanin regulates prolactin release and lactotroph production. Proc Natl Acad Sci USA. 95:1998;12,671-12,676.
57. Hohmann J. G., Cadd G. C., Teal T. H., Clifton D. K., Steiner R. A. Transgenic mice that overexpress the galanin gene in brainstem neurons. Soc Neurosci. 23:1997;729.
58. Baranowska B., Wasilewska-Dziubinska E., Radzikowsak M., Plonowski A., Roguski K. Neuropeptide Y, galanin, and leptin release in obese women and in women with anorexia nervosa. Metabolism. 46:1997;1384-1389.
59. Invitti C., Brunani A., Pasqualinotto L., Dubini A., Bendinelli P., Maroni P., Cavagnini F. Plasma galanin concentrations in obese, normal weight and anorectic women. Int J Obesity Related Metabol Disord. 19:1995;347-349.
60. Berrettini W. H., Kaye W. H., Sunderland T., May C., Gwirtsman H. E., Mellow A., Albright A. Galanin immunoreactivity in human CSF: studies in eating disorders and Alzheimer's disease. Neuropsychobiology. 19:1988;64-68.
61. degli Uberti E. C., Ambrosio M. R., Bondanelli M., Trasforini G., Margutti A., Valentini A., Rossi R., Franceschetti P. Human galanin reduces plasma norepinephrine levels in man. J Clin Endocrinol Metabol. 80:1995;1894-1898.
62. degli Uberti E. C., Bondanelli M., Margutti A., Ambrosio M. R., Valentini A., Campo M., Franceschetti P., Zatelli M. C., Pansini R., Trasforini G. Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide. Neuroendocrinology. 64:1996;398-404.
63. Bauer F. E., Ginsberg L., Venetikou M., MacKay D. J., Burrin J. M., Bloom S. R. Growth hormone release in man induced by galanin, a new hypothalamic peptide. Lancet. 2:1986;192-194.
64. Carey D. G., Iismaa T. P., Ho K. Y., Rajkovic I. A., Kelly J., Kraegen E. W., Ferguson J., Inglis A. S., Shine J., Chisholm D. J. Potent effects of human galanin in man: growth hormone secretion and vagal blockade. J Clin Endocrinol Metabol. 77:1993;90-93.
65. Loche S., Pintus S., Cella S. G., Boghen M., Vannelli S., Benzo L., Müller E. E., Corda R., Pintor C. The effect of galanin on baseline and GHRH-induced growth hormone secretion in obese children. Clin Endocrinol. 33:1990;187-192.
66. Bauer F. E., Zintel A., Kenny M. J., Calder D., Ghatei M. A., Bloom S. R. Inhibitory effect of galanin on postprandial gastrointestinal motility and gut hormone release in humans. Gastroenterology. 97:1989;260-264.
67. Nagase H., Bray G. A., York D. A. Effect of galanin and enterostatin on sympathetic nerve activity to interscapular brown adipose tissue. Brain Res. 709:1996;44-50.
68. Inui A. Neuropeptide Y feeding receptors: are multiple subtypes involved? Trends Pharmacol Sci. 20:1999;43-46.
69. Crawley, J. N. Fiske, S. M. Austin, M. C. Givens, B. S. Behavioral actions of galanin and galanin fragments. Hökfelt, T.Bartfai, T.Jacobowitz, D.Ottoson, D. Galanin: A New Multifunctional Peptide in the Neuroendocrine System. Wenner-Gren International Symposium Series, 58, London, Macmillan Press, 1991, 377, 392.